Does SECUKINUMAB Cause Injection site induration? 31 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Injection site induration have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.0% of all adverse event reports for SECUKINUMAB.
31
Reports of Injection site induration with SECUKINUMAB
0.0%
of all SECUKINUMAB reports
0
Deaths
10
Hospitalizations
How Dangerous Is Injection site induration From SECUKINUMAB?
Of the 31 reports, 10 (32.3%) required hospitalization.
Is Injection site induration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Injection site induration?
ETANERCEPT (1,451)
NALTREXONE (866)
ADALIMUMAB (577)
GLATIRAMER (382)
DUPILUMAB (376)
INTERFERON BETA-1A (254)
EVOLOCUMAB (229)
ENBREL (218)
LEUPROLIDE (207)
IXEKIZUMAB (177)
Which SECUKINUMAB Alternatives Have Lower Injection site induration Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG